In an animal model, NAFLD is reported to be associated with decreased muscle mass and strength as well as decreased IGF-1 levels, suggesting that decreased IGF-1 may contribute to the development of NAFLD-related sarcopenia (106). This evidence concerns the gene IGF1 and metabolic dysfunction-associated steatotic liver disease.